Relation of aspirin failure to clinical outcome and to platelet response to aspirin in patients with acute myocardial infarction

American Journal of Cardiology

Volumn 107, Issue 3, 2011, Pages 339-342

  Beigel, Roy ^a   Hod, Hanoch ^a   Fefer, Paul ^a   Asher, Elad ^a   Novikov, Ilia ^b   Shenkman, Boris ^a   Savion, Naphtaly ^c   Varon, David ^d   Matetzky, Shlomi ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DEATH; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIGHT TRANSMITTED AGGREGOMETRY; LOADING DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET DEPOSITION; PRIORITY JOURNAL; RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; RISK FACTORS; TREATMENT FAILURE;

EID: 78951483438     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.09.025     Document Type: Article

References (24)

1. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
2. E.L. Portnay, J.M. Foody, S.S. Rathore, Y. Wang, F. Masoudi, and J.P. Curtis Prior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarction J Am Coll Cardiol 46 2005 967 974
3. M. Cohen, P.C. Adams, R. McBride, H. Blanke, and V. Fuster Prospective comparison of patient characteristics and outcome of non-prior aspirin users versus aspirin users with unstable angina or nonQ-wave myocardial infarction treated with combination antithrombotic therapy J Thromb Thrombolysis 4 1997 275 280
4. F.A. Spencer, J.J. Santopinto, J.M. Gore, R.J. Goldberg, K.A. Fox, M. Moscucci, K. White, and E.P. Gurfinkel Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (the Global Registry of Acute Coronary Events [GRACE]) Am J Cardiol 90 2002 1056 1061
5. D. Garcia-Dorado, P. Theroux, P. Tornos, A. Sambola, J. Oliveras, M. Santos, and J.S. Soler Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes Circulation 92 1995 1743 1748
6. J.H. Alexander, R.A. Harrington, R.H. Tuttle, L.G. Berdan, A.M. Lincoff, J.W. Deckers, M.L. Simons, A. Guerci, J.S. Hochman, R.G. Wilcox, M.M. Kitt, P.R. Eisenberg, R.M. Califf, E.J. Topol, K. Karsh, W. Ruzyllo, J. Stepinska, P. Widimsky, J.B. Boland, and P.W. Armstrong Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy Am J Cardiol 83 1999 1147 1151
7. E.M. Antman, M. Cohen, P.J. Bernink, C.H. McCabe, T. Horacek, G. Papuchis, B. Mautner, R. Corbalan, D. Radley, and E. Braunwald The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA 284 2000 835 842
8. G.I. Lancaster, C.J. Lancaster, D. Radley, and M. Cohen Prior aspirin use in unstable angina predisposes to higher risk: the aspirin paradox Int J Cardiol 80 2001 201 207
9. J. Santopinto, E.P. Gurfinkel, V. Torres, E. Marcos, G.E. Bozovich, B. Mautner, C.H. McCabe, and E.M. Antman Prior aspirin users with acute nonST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin Am Heart J 141 2001 566 572
10. D. Varon, R. Dardik, B. Shenkman, S. Kotev-Emeth, N. Farzame, I. Tamarin, and N. Savion A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions Thromb Res 85 1997 283 294
11. J. Mikkelsson, M. Eskola, K. Nikus, P.J. Karhunen, and K. Niemela Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-upa large series of all-comers Ann Med 40 2008 296 302
12. T. Bauer, A. Gitt, R. Zahn, C. Junger, O. Koeth, F. Towae, K. Bestehorn, J. Senges, U. Zeymer Acute Coronary Syndrome Registry (ACOS) Investigators Impact of chronic antithrombotic therapy on hospital course of patients with acute myocardial infarction Clin Cardiol 32 2009 718 723
13. P.A. Gum, K. Kottke-Merchant, P.A. Welsh, J. White, and E.J. Topol A prospective, blinded, determination, of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 2003 961 965
14. P.A. Gum, K. Kottke-Merchant, E.D. Poggio, H. Gurm, P.A. Welsh, L. Brooks, S.K. Sapp, and E.J. Topol Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol 88 2001 230 235
15. J. Valles, M.T. Santos, M.P. Fuset, A. Moscardo, M. Ruano, F. Perez, M. Pinon, S. Brena, and J. Aznar Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction Am J Cardiol 99 2007 19 25
16. E.I. Lev, C.L. Alvias, M.E. Arikan, B.P. Dave, J.F. Granada, T. DeLao, A. Tellez, K. Maresh, and N.S. Kleiman Platelet reactivity in patients with subacute stent thrombosis compared with nonstent-related acute myocardial infarction Am Heart J 153 suppl 2007 41.e1 41.e6
17. P. Harrison, I. Mackie, A. Mathur, M.S.C. Robinson, Y. Hong, J.D. Erusalimsky, S.J. Machin, and J.F. Martin Platelet hyper-function in acute coronary syndromes Blood Coagul Fibrinolysis 16 2005 557 562
18. M.D. Linden, M.I. Furman, A.L. Frelinger, M.L. Fox, M.R. Barnard, K. Przylenk, and A.D. Michelson Indices of platelet activation and the stability of coronary artery disease J Thromb Haemost 5 2007 761 765
19. N. Zimmermann, A. Wenk, U. Kim, P. Kienzle, A.A. Weber, E. Games, K. Schror, and T. Hohlfeld Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery Circulation 108 2003 542 547
20. S. Guthikoda, E.I. Lev, R. Patel, T. DeLao, A.L. Bergeron, J.F. Dong, and N.S. Kleiman Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin J Thromb Haemost 5 2007 490 496
21. A. Modica, F. Karlsson, and T. Mooe Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection J Thromb Haemost 5 2007 507 511
22. N. Zimmermann, P. Kienzle, A.-A. Weber, J. Winter, E. Games, K. Schror, and T. Hohlfeld Aspirin resistance after coronary artery bypass grafting J Thorac Cardiovasc Surg 121 2001 982 984
23. M.J. Alberts, D.L. Bergman, E. Molner, B.D. Jovanovic, I. Ushiwata, and J. Teruya Antiplatelet effect of aspirin in patients with cerebrovascular disease Stroke 35 2004 175 178
24. A.L. Frelinger, M.I. Furman, M.D. Linden, Y. Li, M.L. Fox, M.R. Barnard, and A.D. Michelson Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1 and cyclooxygenase-2- independent pathway: a 700-patient study of aspirin resistance Circulation 113 2006 2888 2896